NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,221,751 | -15.5% | 51,264 | -16.3% | 0.40% | -12.2% |
| Q2 2023 | $6,178,404 | -43.2% | 61,229 | -48.2% | 0.45% | -46.2% |
| Q1 2023 | $10,872,800 | -24.0% | 118,181 | -25.1% | 0.84% | -27.3% |
| Q4 2022 | $14,310,068 | +12.4% | 157,768 | -5.8% | 1.15% | +1.7% |
| Q3 2022 | $12,730,000 | -42.5% | 167,476 | -36.1% | 1.13% | -37.6% |
| Q2 2022 | $22,157,000 | -10.7% | 262,171 | -7.3% | 1.81% | +0.7% |
| Q1 2022 | $24,819,000 | -2.2% | 282,836 | -2.5% | 1.80% | +2.7% |
| Q4 2021 | $25,380,000 | +3.5% | 290,147 | -2.9% | 1.75% | -5.5% |
| Q3 2021 | $24,511,000 | -14.5% | 298,727 | -5.0% | 1.85% | -14.2% |
| Q2 2021 | $28,683,000 | +6.2% | 314,376 | -0.5% | 2.16% | +2.6% |
| Q1 2021 | $27,012,000 | -11.6% | 315,801 | -2.4% | 2.10% | -13.3% |
| Q4 2020 | $30,556,000 | +6.5% | 323,602 | -1.9% | 2.43% | -2.1% |
| Q3 2020 | $28,687,000 | -3.0% | 329,775 | -2.5% | 2.48% | -6.0% |
| Q2 2020 | $29,568,000 | +5.2% | 338,377 | -0.9% | 2.64% | -6.3% |
| Q1 2020 | $28,114,000 | -12.6% | 341,525 | +0.5% | 2.82% | +6.5% |
| Q4 2019 | $32,162,000 | -0.0% | 339,660 | -8.3% | 2.64% | +0.5% |
| Q3 2019 | $32,167,000 | -11.9% | 370,448 | -7.3% | 2.63% | -12.5% |
| Q2 2019 | $36,502,000 | -8.1% | 399,587 | -3.3% | 3.00% | -10.0% |
| Q1 2019 | $39,705,000 | +12.0% | 413,114 | -0.2% | 3.34% | +0.3% |
| Q4 2018 | $35,466,000 | -1.9% | 413,914 | -1.3% | 3.33% | +11.2% |
| Q3 2018 | $36,139,000 | +13.8% | 419,382 | -0.2% | 3.00% | +5.4% |
| Q2 2018 | $31,750,000 | -6.5% | 420,307 | -0.0% | 2.84% | -8.0% |
| Q1 2018 | $33,949,000 | -3.8% | 420,360 | +0.0% | 3.09% | +1.0% |
| Q4 2017 | $35,301,000 | -1.9% | 420,198 | +0.3% | 3.06% | -4.9% |
| Q3 2017 | $35,992,000 | +2.4% | 419,073 | -0.5% | 3.22% | +0.2% |
| Q2 2017 | $35,158,000 | +12.2% | 421,168 | -0.2% | 3.21% | +11.0% |
| Q1 2017 | $31,346,000 | +2.3% | 422,008 | +0.3% | 2.89% | +0.2% |
| Q4 2016 | $30,638,000 | -10.2% | 420,631 | -2.6% | 2.89% | -7.7% |
| Q3 2016 | $34,112,000 | -4.5% | 432,011 | -0.2% | 3.13% | -3.5% |
| Q2 2016 | $35,722,000 | +15.9% | 432,871 | +1.7% | 3.24% | +13.8% |
| Q1 2016 | $30,812,000 | -15.9% | 425,761 | +0.0% | 2.85% | -19.0% |
| Q4 2015 | $36,627,000 | -6.7% | 425,706 | -0.3% | 3.52% | -10.7% |
| Q3 2015 | $39,252,000 | -6.8% | 427,031 | -0.3% | 3.94% | +0.5% |
| Q2 2015 | $42,137,000 | -0.7% | 428,428 | -0.5% | 3.92% | +1.3% |
| Q1 2015 | $42,450,000 | +6.7% | 430,488 | +0.3% | 3.87% | +10.0% |
| Q4 2014 | $39,771,000 | -2.0% | 429,338 | -0.5% | 3.51% | -2.6% |
| Q3 2014 | $40,572,000 | +2.5% | 431,298 | -1.3% | 3.61% | +5.3% |
| Q2 2014 | $39,590,000 | +5.9% | 436,993 | -0.6% | 3.43% | +1.2% |
| Q1 2014 | $37,376,000 | +4.7% | 439,801 | -1.0% | 3.38% | +0.8% |
| Q4 2013 | $35,701,000 | +3.6% | 444,156 | -1.1% | 3.36% | -3.1% |
| Q3 2013 | $34,447,000 | +6.5% | 449,057 | -1.8% | 3.46% | +2.5% |
| Q2 2013 | $32,335,000 | – | 457,212 | – | 3.38% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |